Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Recruiting 336Active not recruiting 167Completed 102Not yet recruiting 73Terminated 23Enrolling by invitation 9Suspended 7Withdrawn 4Available 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 17Lymphoid 16Thoracic 13Other hematologic neoplasm 10Gastrointestinal 10Breast 6Tumor-Agnostic 5Plasma cell 5CNS 5Other solid neoplasm 4Head & Neck 4Dermatologic 4Gynecologic 3Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Head and Neck Neoplasms 3Tinnitus 1Ototoxicity 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Hearing Loss 1Deafness 1

Interventions

ebselen 1balstilimab 1Radiotherapy, Intensity-Modulated 1NOP-bolus regimen 1Gravitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Head & Neck × 90 days × Clear all
NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Withdrawn
Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT05363709 2026-05-12

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Head & Neck

Oropharyngeal Neoplasms

NCT01536782 2026-04-29

Optimal Tube Feeding Method in Head and Neck Cancer Patients

Baylor Research Institute

Phase NA Withdrawn
Head & Neck

Head and Neck Neoplasms

NCT03953352 2026-04-15

GIRAFE

Institut Claudius Regaud

Phase NA Withdrawn
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡